TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Limitation in social and personal roles
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Proportion of screened patients receiving a screening report
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Diagnosis of diabetic retinopathy (DR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Referral to an ophthalmologist
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: In-hospital reinfarction rate
Endpoint domain: Adverse events/effects
Primary endpoint: Thirty day and one year mortality
Endpoint domain: Mortality/survival
Primary endpoint: Duration of treatment phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correction of Class II subdivision malocclusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: side-to-side laxity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACL-QoL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Median time to PA acquisition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: change in HAQ score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient coping
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: onset of psychosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: onset of epilepsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: interval between onset of epilepsy and onset of psychosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: pain score (VAS) at 30 min postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity score of pain at sexual activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in bacterial adhesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: sternal infection morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: Major complications requiring secondary surgery
Endpoint domain: Adverse events/effects
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: 1-year quit rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total PME levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total PEtn levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Willingness-to-pay
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Serum concentration of digoxin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elimination half-life time (T1/2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase life expectancy
Endpoint domain: Mortality/survival
Primary endpoint: Effectiveness in removing extrinsic dental stain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of homocysteine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: peak CVC values during WMTS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: aversiveness of sound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective rankings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: number of haemodialysis sessions required prior to recovery of renal function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: number of oliguric days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: change in voluntary isometric force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative probability of HSV-2 seroconversion
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of high-risk HPV genotypes
Endpoint domain: Adverse events/effects
Primary endpoint: resolution of colonic dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: increase in stool evacuations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: increase in flatus evacuations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Discussion about the vaccine with physician
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Intensity of TFSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Favorable answers percentage
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of job strain at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of volume receiving 100% of the prescribed dose (V(100))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average seed cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Average operating room time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Index beta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patient satisfaction at follow-up
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Efficacy in sclerosing leg telangiectasia and reticular feeding veins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse sequelae from POL treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Brain CT results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of chronic postoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Power output measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative systemic inflammatory response syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in cardiovascular morbidity and mortality risk
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in vWF levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in sVCAM‐1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Exercise participation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: maximum voluntary bite force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum voluntary jaw opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dietary intake of egg and egg products
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Energy percentage from protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Interference with sleep and daily activities
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: daily urinary incontinence (UI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: receipt of recommended interventions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pad test measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in daily incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dyspnea levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental RH knowledge score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for technique
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PCSK9 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in 24-hour mean ambulatory systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of oral mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intensity of oral mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of oral mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ostomy adjustment level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Stoma self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PSQI scores after treatment
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: lasting time of postoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: healing time of incision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cleared vessels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain at injection sites
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of low birth weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of S. pneumoniae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Prevalence of S. aureus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Prevalence of azithromycin-resistant S. pneumoniae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Visual Field Deficits (VFD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seizure-free rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Liver regeneration rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported heroin use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wrinkles improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for email communication about procedures
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Desire for educational videos in patient education
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Appropriateness of text message communication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Expanded Disability Status Scale progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T2 burden of disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain VAS scores with movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain VAS scores at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to drink
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No claudication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: NHP pain scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Plasma levels of bupivacaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in IOP measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease activity score (DAS28) response/remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographic assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total health-care costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinically significant tics
Endpoint domain: Adverse events/effects
Primary endpoint: Medication history errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discharge prescription errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of inpatient prescribing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MLA relocation from post procedure to three years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cure rates at 6 months post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of fungal colonisation
Endpoint domain: Adverse events/effects
Primary endpoint: IGF1 C(max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: IGFBP3 C(max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: IGF1 SDS normalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cardiac output determination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in instrumental ADL
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Oswestry Disability Index (ODI) for improvement in disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Past-30-day alcohol problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Victimization
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Lower esophageal sphincter basal pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of increase in VLDL particles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Average drinks consumed per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive Predictive Value (PPV) for detection of significant coronary stenoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of revascularisations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical events (cardiac death, myocardial infarction, unstable angina pectoris, revascularisation and readmission for chest pain)
Endpoint domain: Adverse events/effects
Primary endpoint: Serum levels of total cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum HDL cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Weight perception and body dissatisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attempt to lose weight
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Prolapse impact and role
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Stress incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Documentation of breast lumps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: State shame experienced during training
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time spent with the patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to passage of flatus and stools
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Binocular distance-corrected intermediate visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average time T1/2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: average retention %GE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Nottingham Adjustment Scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Circadian melatonin profile disruption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of unsafe rugs and mats
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of unsafe steps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of rooms with trailing cords
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of paresthesiae
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of venous cannulation
Endpoint domain: Adverse events/effects
Primary endpoint: ability to advance catheter into epidural space
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Left ventricular mass index change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in severity of pruritus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in severity of lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance to a low caloric diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feelings of fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Improvement in Rhinosinusitis Outcomes Measure 31 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased use of sinus medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: anti-heat shock protein 65 titres
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in STAI State Anxiety scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in STAI Trait Anxiety scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Acceptability of alcohol screening and intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adhesiveness scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of migraine like headaches
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak expiratory flow improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall survival with successful primary site preservation
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of Clostridium difficile infections
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of active-play video games integration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adherence to training sessions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Intraocular pressure readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Blast count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vWF:Ag levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: incidence of major bleeding or clinically relevant nonmajor bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: SLC2A1 mRNA expression in adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight loss from baseline to 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants achieving ≥5% weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to self-monitoring caloric intake
Endpoint domain: Life impact
Endpoint subdomain: Other resource use
Primary endpoint: Total Motor Score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased hazard of perforation or therapeutic penetrating keratoplasty
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Decreased infiltrate and/or scar size at 3 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased logMAR visual acuity at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in high-calorie food preferences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to complete removal of eschar
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Learning curve of intubation devices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken to position the endotracheal tube
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expired tidal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SCH (Skin Capacitance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Postoperative pain in movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: wmFEV(1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: % rescue-free
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: new caries development on first permanent molars
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes